UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                    Washington, D.C.  20549
                          Form 10-Q


 X     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE 
---    SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 1996
                               ------------------
                                or

       TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE 
---    SECURITIES EXCHANGE ACT OF 1934

For the transition period from       to 
                                        
Commission file number   1-07151
                         -------

                           THE CLOROX COMPANY
-----------------------------------------------------------------
     (Exact name of registrant as specified in its charter) 
                                                       
     DELAWARE                                     31-0595760
-----------------------------------------------------------------
(State or other jurisdiction                  (I.R.S. Employer 
  of incorporation or organization)         Identification number)
                                                       
1221 Broadway - Oakland, California              94612 - 1888
-----------------------------------------------------------------
(Address of principal executive offices)               
                                                       
Registrant's telephone number,                    (510)-271-7000
 (including area code)                            ---------------

-----------------------------------------------------------------
   (Former name, former address and former fiscal year, 
              if changed since last report)

Indicate by check mark whether the registrant  (1)  has filed all 
reports required to be filed by Section 13 or 15(d) of the 
Securities Exchange Act of 1934 during the preceding 12 months (
or for such shorter period that the registrant was required to 
file such reports), and  (2)  has been subject to such filing 
requirements for the past 90 days.                          

          Yes         X           No                  
                  --------            -------

                                                       
As of September 30, 1996 there were 51,617,112 shares outstanding
of the registrant's common stock (par-value -  $1.00), the 
registrant's only outstanding class of stock. 

-----------------------------------------------------------------
                                                       
                                               Total  pages 9
                                                            1
                                                           --

<PAGE>


                               THE CLOROX COMPANY 
                         
                         
                         
                         
PART 1.  Financial Information                         Page No. 
         ---------------------                         ---------
                         
  Item 1.  Financial Statements           
                         
           Condensed Statements of Consolidated
            Earnings
             Three Months Ended September 30, 1996
               and 1995                                    3 
                          
                     
           Condensed Consolidated Balance Sheets           
             September 30, 1996 and June 30, 1996          4 
                          
                     
           Condensed Statements of Consolidated 
            Cash Flows            
              Three Months Ended September 30, 1996
               and 1995                                    5 
                          
                         
            Notes to Condensed Consolidated 
             Financial Statements                          6 
                         
                         
  Item 2.  Management's Discussion and Analysis 
            of Results of Operations and 
            Financial Condition                           7-8 


                                                            2
                                                           --

<PAGE>

<TABLE>
<CAPTION>

                                      PART I - FINANCIAL INFORMATION
                                       Item 1. Financial Statements
                                    The Clorox Company and Subsidiaries
                                Condensed Statements of Consolidated Earnings
                                ---------------------------------------------
                                   (In thousands, except per-share amounts)

                                                                                     Three Months Ended
                                                                                     ------------------
                                                                                9/30/96                9/30/95
                                                                              -----------            -----------
<S>                                                                           <C>                    <C>
Net Sales                                                                     $ 590,773              $ 518,486 
                                                                              -----------            -----------
Costs and Expenses                                                      
     Cost of products sold                                                      257,361                231,333 
                                                     
     Selling, delivery and administration                                       116,594                 98,656 
                                                     
     Advertising                                                                 88,974                 72,482 
                                                     
     Research and development                                                    10,498                 10,202 
                                                     
     Interest expense                                                            10,497                  7,772 
                                                     
     Other income                                                                (1,973)                  (567)
                                                                              -----------            -----------

          Total costs and expenses                                              481,951                419,878 
                                                                              -----------            -----------

Earnings before income taxes                                                    108,822                 98,608 
                                                     
Income Taxes                                                                     43,312                 39,829
                                                                              -----------            -----------

Net Earnings                                                                  $  65,510              $  58,779
                                                                              ===========            ===========
                               
Earnings per Common Share                                                     $    1.27              $    1.12
                                                     
Dividends per Share                                                           $    0.58              $    0.53
                                                     
Weighted Average Shares Outstanding                                              51,546                 52,354 
                                                      



See Notes to Condensed Consolidated Financial Statements.


                                                                                                               3
                                                                                                              --
</TABLE>
<PAGE>

<TABLE>
<CAPTION>

                                 PART I - FINANCIAL INFORMATION (Continued)
                                       Item 1. Financial Statements
                                    The Clorox Company and Subsidiaries
                                   Condensed Consolidated Balance Sheets
                                   -------------------------------------
                                              (In thousands)

                                                                             9/30/96                6/30/96
                                                                           -----------            -----------
<S>                                                                        <C>                    <C>
ASSETS                                              
     Current Assets                                         
          Cash and short-term investments                                  $  116,751             $    90,828 
          Accounts receivable, less allowance                                 275,203                 315,106 
          Inventories                                                         147,421                 138,848 
          Deferred income taxes                                                11,139                  10,987 
          Prepaid expenses                                                     20,918                  18,076 
                                                                           -----------            -----------
               Total current assets                                           571,432                 573,845 
                                                  
     Property, Plant and Equipment - Net                                      557,454                 551,437 
                                                  
     Brands, Trademarks, Patents and Other Intangibles                        717,770                 704,669 
                                                  
     Investments in Affiliates                                                 99,668                  99,033 
                                                  
     Other Assets                                                             278,863                 249,910 
                                                                           -----------            -----------
                                                  
     Total                                                                 $ 2,225,187            $ 2,178,894 
                                                                           ===========            ===========
                                                  
LIABILITIES AND STOCKHOLDERS' EQUITY                                                   
     Current Liabilities                                              
          Accounts payable                                                 $   126,764            $   155,366
          Accrued liabilities                                                  278,490                266,192 
          Income taxes payable                                                  39,507                  9,354 
          Commercial paper and short-term borrowings                           184,358                192,683 
          Current maturities of long-term debt                                     179                    291 
                                                                           -----------            -----------
               Total current liabilities                                       629,298                623,886 
                                                  
     Long-term Debt                                                            355,575                356,267 
                                              
     Other Obligations                                                         120,116                117,505 
                                                  
     Deferred Income Taxes                                                     144,289                148,408 
                                              
     Stockholders' Equity                                              
          Common Stock                                                          55,422                 55,422 
          Additional paid-in capital                                           113,076                111,782 
          Retained earnings                                                  1,114,802              1,078,789 
          Treasury shares, at cost                                            (262,770)              (268,652) 
          Cumulative translation adjustments and other                         (44,621)               (44,513) 
                                                                           -----------            -----------
               Stockholders' Equity                                            975,909                932,828 
                                                                           -----------            -----------
                                                 
     Total                                                                 $ 2,225,187            $ 2,178,894 
                                             
                                              
See Notes to Condensed Consolidated Financial Statements.                                              
                                                                                                            4 
                                                                                                           --
</TABLE>

<PAGE>


<TABLE>
<CAPTION>

                                 PART I - FINANCIAL INFORMATION (Continued)
                                       Item 1. Financial Statements
                                    The Clorox Company and Subsidiaries
                               Condensed Statements of Consolidated Cash Flows
                               -----------------------------------------------
                                               (In thousands)
                                                                                     Three Months Ended
                                                                                     ------------------
                                                                                9/30/96                9/30/95
                                                                              -----------            -----------
<S>                                                                           <C>                    <C>

Operations:                                              
     Net earnings                                                             $   65,510             $   58,779 
     Adjustments to reconcile to net cash provided by operating activities:                                     
          Depreciation and amortization                                           26,744                 26,478 
          Deferred income taxes                                                      840                  3,300 
          Other                                                                    5,315                  4,628 
          Effects of changes in:                                        
               Accounts  receivable                                               42,103                 93,933 
               Inventories                                                        (8,273)                (3,884) 
               Prepaid expenses                                                   (3,084)                 1,372 
               Accounts payable                                                  (28,635)               (22,603) 
               Accrued liabilities                                                (3,770)               (18,065) 
               Income taxes payable                                               25,042                 24,211 
                                                                              -----------            -----------
                                                
               Net cash provided by operations                                   121,792                168,149 
                                             
Investing Activities:                                                
     Property, plant and equipment                                               (23,033)               (12,162) 
     Disposal of property, plant and equipment                                       515                  2,369 
     Businesses purchased                                                        (22,207)               (60,427) 
     Other                                                                       (17,043)               (15,736) 
                                                                              -----------            -----------
                                                
               Net cash used for investment                                     (61,768)                (85,956) 
                                                                              -----------            -----------
                                                
Financing Activities:                                              
     Long-term borrowings                                                           968                    - 
     Long-term debt and other obligations  repayments                            (6,942)                (8,789) 
     Commercial paper, net                                                       (5,348)               (38,881) 
     Cash dividends                                                             (29,888)               (27,804) 
     Treasury stock purchased                                                      -                   (18,819) 
     Employee stock plans                                                         7,109                  2,616 
                                                                              -----------            -----------
                                               
               Net cash used for financing                                      (34,101)               (91,677) 
                                                                              -----------            -----------
                                                
Net Increase (Decrease) in Cash and Short-Term Investments                       25,923                 (9,484) 
Cash and Short-Term Investments:                                                 
     Beginning of period                                                         90,828                137,330 
                                                                              -----------            -----------
                                                
     End of period                                                            $ 116,751                127,846 
                                                                              ===========            ===========
                                 
                                              
                                              
See Notes to Condensed Financial Statements                                              
                                                                                                             5
                                                                                                            --
</TABLE>

<PAGE>


              PART I - FINANCIAL INFORMATION (Continued)
                    Item 1.  Financial Statements
                 The Clorox Company and Subsidiaries
           Notes to Condensed Consolidated Financial Statements


(1)  The summarized financial information for the three months
     ended September 30, 1996 and 1995 has not been audited, 
     but in the opinion of management, all adjustments  
     (consisting only of normal recurring accruals) necessary for 
     a fair presentation of the results of operations, financial 
     position, and cash flows of The Clorox Company and subsidiaries
     (the Company) have been made.  The results of the three months 
     ended September 30, 1996 should not be considered as necessarily
     indicative of the results for the entire year.



(2)  Inventories at September 30, 1996 and at June 30, 1996 consisted 
     of (in thousands):

                                    9/30/96             6/30/96
                                   ---------           ---------
                                        
     Finished goods and work 
      in process                   $ 91,341            $ 82,261
     Raw materials and supplies      56,080              56,587 
                                   ---------           ---------
          Total                    $147,421            $138,848



(3)  Acquisitions during the quarter were funded from cash and 
     included the Limpido brand of liquid bleach, and an 
     increase of ownership in Technoclor, S.A, both in Columbia.
     These acquisitions were accounted for as purchases.


                                                                6
                                                               --

<PAGE>

             PART I - FINANCIAL INFORMATION (Continued)
          Item 2.  Management's Discussion and Analysis of
           Results of Operations and Financial Condition
           ---------------------------------------------

                   Results of Operations
                   ---------------------

     Comparison of the Three Months Ended September 30, 1996
     -------------------------------------------------------
        with the Three Months Ended September  30, 1995
        -----------------------------------------------

Earnings per share increased 13 percent to $1.27 from $1.12, 
and net earnings increased 11 percent to $65,510,000 from 
$58,779,000 a year ago principally due to a 14 percent 
increase in net sales driven by a 15 percent increase in 
volume.  Domestic volume growth was approximately 10 percent, 
while our international base businesses grew about 13 percent 
with the remaining growth coming from acquisitions that 
occurred in fiscal 1996.  Home cleaning products experienced 
strong volume growth and included strong shipments of 409, 
Soft Scrub, Pine-Sol, Clorox Toilet Bowl Cleaner, and 
S.O.S.  Cat litter was up strongly for the quarter principally 
due to increased distribution of our larger sizes and the 
continued strong growth of the Scoop segment of the category.  
Insecticides were also up strongly principally due to last 
year's acquisition of Black Flag.  Additionally, Brita and 
our  professional products business experienced strong 
volume growth in the quarter, driven principally by new 
distribution for Brita.  International volume growth occurred 
principally in Argentina as well as other markets in Latin 
America and Asia.

Costs of products sold as a percent of net sales was 44 and 
45 percent in the current and year ago quarters, respectively 
and is anticipated to remain in this range for the balance 
of the year.  This quarter's improvement reflects the results 
of certain cost savings measures including our manufacturing 
strategy and our initiatives in the food business.  Raw 
materials costs are relatively stable versus a year ago, 
and increases over the balance of the year may tend to 
mitigate any margin improvement.

Research and development expense was about even with year 
ago period.  Selling,  delivery, and administration expense 
increased 18 percent over the year ago period principally 
due to spending this period on major information technology 
initiatives that are necessary to maintain technological 
competence and prepare for the year 2000 conversion, and 
further international infrastructure investments that include 
the establishment of our own direct sales forces in Canada 
and in some Latin American markets.

Advertising expense increased 23 percent over the year ago 
period principally due to increased media spending across 
all our businesses.  Sales promotional and couponing 
spending increased as well due to promotional activity for 
S.O.S Scrubber Sponges and other new products.  We anticipate 
that for the full year, advertising and sales promotion 
should increase at about the same rate as the growth of sales, 
subject to completion of marketing plans.

Interest expense increased $ 2,725,000 over a year ago due 
to increased borrowing levels for both commercial paper and  
medium term debt associated with acquisitions that occurred 
in fiscal 1996.

                                                         7.
                                                        --

<PAGE>
             PART I - FINANCIAL INFORMATION (Continued)
          Item 2.  Management's Discussion and Analysis of
           Results of Operations and Financial Condition
           ---------------------------------------------

                 Liquidity and Capital Resources
                 -------------------------------


The Company's financial position remains strong principally due 
to cash provided by operations during the quarter. Accounts 
receivable and accounts payable both decreased from June 30, 
1996 reflecting normal seasonal variations of the charcoal 
and insecticides businesses.  Inventories are higher due to 
international growth and acquisitions as well as for increased 
Brita volume.  We expect our inventories to increase during 
the next two fiscal quarters to support the seasonal charcoal 
and insecticides businesses.

The Company has approved the use of interest rate derivative 
instruments such as interest rate swaps in order to manage the 
impact of interest rate movements on interest expense.  These 
instruments have the effect of converting fixed rate interest 
to floating, or floating to fixed.  The conditions under which 
derivatives can be used are set forth in a Company Policy 
Statement and include a restriction on the amount of such 
activity to a designated portion of existing debt, a limit on 
the term of any derivative transaction, and a specific prohibition 
on the use of any leveraged derivatives.

Management believes the Company has access to additional 
capital through existing lines of credit and from public and 
private sources should the need arise.


                                                             8
                                                            --

<PAGE>








                     S I G N A T U R E
                     -----------------

Pursuant to the requirements of the Securities Exchange Act of 
1934, the registrant has duly caused this report to be signed 
on its behalf by the undersigned thereunto duly authorized.


                                   THE CLOROX COMPANY
                                   (Registrant)




DATE November 13, 1996           BY /S/ HENRY J. SALVO, JR.
     -----------------              -----------------------
                                        Henry J. Salvo, Jr.
                                        Vice-President - 
                                        Controller


                                                        9
                                                       --